In conclusion, this study found that serum CGRP, IL‐2, and IL‐10 were increased in HSP patients, indicating that CGRP may be the major pain‐inducing mediator, and IL‐2, IL‐10 may contribute to anti‐inflammatory and analgesic effects. The gene discussed is IL2; the disease is hereditary spastic paraplegia.